Key points from article :
Drug suppresses the effects of the Huntington’s mutation that causes irreversible damage to the brain.
Huntington’s is caused by a single gene defect that is passed down through families.
Ionis-HTTRx works by intercepting the messenger molecule before the harmful protein can be made.
University College London led the phase 1 trial of synthetic strand of DNA drug.
Could potentially be adapted to target Alzheimer’s and Parkinson’s.
